Adenosine and chronic ischemia of the lower limbs
- 1 November 2000
- journal article
- Published by SAGE Publications in Vascular Medicine
- Vol. 5 (4) , 243-250
- https://doi.org/10.1177/1358836x0000500408
Abstract
Adenosine is an endogenous nucleoside with multiple biological properties which plays a central role in the pathophysiology of tissue ischemia. Adenosine signals an imbalance between oxygen demand and supply, and it initiates responses to redress such a discrepancy. Besides its vasodilating properties, adenosine possesses anti-platelet and anti-neutrophil activities and provides cytoprotection. Adenosine is presumably the main mediator of the preconditioning phenomenon. During ischemia of the lower limbs, adenosine plays a physiological role by inducing vasodilatation and by preventing microcirculatory failure. Exercise training prolongs claudication distance possibly by inducing pulse increases of adenosine and consequently skeletal muscle preconditioning. Moreover, the adenosine increase which follows the administration of some drugs, such as buflomedil and propionylcarnitine, opens new perspectives in the management of leg ischemia. In fact, the concept arises of an ischemic (exercise-dependent) or pharmacologic preconditioning in the treatment of patients with claudication.Keywords
This publication has 119 references indexed in Scilit:
- Adenovirus-Mediated Gene Transfer to Lower Limb Artery of Patients with Chronic Critical Leg IschemiaHuman Gene Therapy, 1998
- The Role of Intracellular pH in the Control of Adenosine Output from Red Skeletal MuscleNeurosignals, 1995
- Identification of Adenosine A2 Receptor-cAMP System in Human Aortic Endothelial CellsBiochemical and Biophysical Research Communications, 1994
- Identification of high-risk patients with left main and three-vessel coronary artery disease by adenosine-single photon emission computed tomographic thallium imagingAmerican Heart Journal, 1993
- Inhibition of adenosine metabolism increases myocardial interstitial adenosine concentrations and coronary flowJournal of Molecular and Cellular Cardiology, 1992
- Stimulation of coronary collateral growth: Current developments in angiogenesis and future clinical applicationsAmerican Heart Journal, 1992
- AICA‐Riboside: Safety, Tolerance, and Pharmacokinetics of a Novel Adenosine‐Regulating AgentThe Journal of Clinical Pharmacology, 1991
- DipyridamoleNew England Journal of Medicine, 1987
- The coronary endothelium: a highly active metabolic barrier for adenosineBasic Research in Cardiology, 1985
- Vergleichende Untersuchungen über die Bildung von Adenosin im Myokard verschiedener Tierspecies bei SauerstoffmangelKlinische Wochenschrift, 1966